《大行報告》花旗升美高梅中國(02282.HK)目標價至15元 上季業績勝預期
花旗發表報告表示,美高梅中國(02282.HK)今年第三季總收益錄57.77億元,按年升22%(按季升4%),物業EBITDA錄15.49億元,按年增長39%(按季升6%),分別略優於該行原預期54.98億元及14.96億元,主要受惠於中場(按年升39%及按季升8%),及受惠有利貴賓廳贏率。
該行估計,美高梅中國市佔率提升110個基點至10.2%,為反映上季業績表現,決定上調對其預測2019年至2021年純利預測各2.1%、2.5%及3%,分別至22.79億、28.16億及35.26億元。
花旗上調美高梅中國目標價,由14元升至15元,按綜合方式作估值,指仍為該行濠賭股中首選,維持「買入」投資評級,指旗下美獅美高梅表現呈上升,料公司短期EBITDA增長或會為市場帶來驚喜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.